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http://dx.doi.org/10.1016/j.jmii.2015
1684-1182/Copyright ª 2015, TaiwanAbstract Background: Hepatitis C virus (HCV) genotype is important for identifying effective
antiviral therapy, evaluating pathogenic severity, and tracking transmission routes. In
Thailand, HCV genotypes 3 and 1 are the most common. We have previously demonstrated
an increasing appearance of genotype 6 in HCV infections in Thailand. However, only limited
epidemiological data on genotype 6 in Thailand are available. This study aimed to characterize
HCV genotype 6 among apparently healthy Thai blood donors.
Methods: In total, 240 blood samples were collected from Phitsanulok Regional Blood Center,
Phitsanulok, Thailand. RNA was reverse transcribed and amplified by the nested polymerase
chain reaction. HCV genotyping was performed by direct sequencing and phylogenetic tree
analysis of core sequences. Amino acid polymorphism of various subtypes of HCV genotype 6
was investigated.
Results: Of the 240 samples, 192 were successfully sequenced for the core region and 84 were
determined to be of HCV genotype 6 by phylogenetic analysis. The most prevalent HCV-6 sub-
types were 6f > 6n > 6c > 6i. Amino acid sequences of the partial core region among these four
subtypes differed by one to seven residues.
Conclusion: For HCV-6, the subtype 6f was commonly found in Thai blood donors. Comparison
of core protein from various HCV-6 subtypes showed substantial polymorphisms, which may
form the basis of future studies using samples from patients with clear HCV histories. This
feature can be applied to therapies tailored to particular genotype variants.
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+ MODELIntroductionA common cause of acute and chronic liver diseases arises
from hepatitis C virus (HCV), which is classified into six
major genotypes (genotypes 1e6) and more than 80 sub-
types. HCV genotyping is considered important for predict-
ing a sustained virologic response. Thus, the HCV genotype is
an important determinant of effective treatment methods
and vaccine development. Antiviral drugs including pegy-
lated interferon-alpha, ribavirin, boceprevir, and telaprevir
are current treatments or are under development.1,2
The global HCV incidence rate is about 3%; however, the
rate varies by region and by genotype: genotypes 1e3
predominate in Europe, North and South America, and
Japan 3; genotype 4 is most frequent in North Africa and the
Middle East; genotype 5 is common in South Africa 4,5; and
genotype 6 is largely confined to East/Southeast Asia.6,7
However, data based on continents conceal local varia-
tions, which might provide more accurate insights about
the spread of this virus. There have been several studies
demonstrating such localization in, for example, Thailand,
where HCV genotype frequencies of 3a > 1 > 6 > 2 are
found.8,9 More recently, another region of Thailand
demonstrated the prevalence of genotypes 3a > 6 > 1, with
genotype 6 in particular being more prevalent in HCV in-
fections.7 Akkarathamrongsin et al8 found a prevalence of
HCV-6 subtypes in Thai people residing mainly in the central
region of the country and subtypes 6f, 6n, 6i, 6j, and 6e
were detected using phylogenetic analysis based on the
core and NS5B sequences. Another study demonstrated
prevalence of infections due to subtypes 6a, 6f, and 6n in
four disparate provinces of Thailand.9 However, failure to
detect genotypes 4 or 5 does not preclude their existence in
other parts of Thailand.
HCV genotyping commonly uses restriction fragment
length polymorphism or polymerase chain reaction (PCR)
using type-specific primers and hybridization with specific
oligonucleotide probes. However, the genotype specificity
of these methods is sometimes questionable and indeed our
previous study failed to genotype several samples. By
contrast, direct nucleotide sequencing is more reliable for
genotyping HCV samples. Although there has been limited
epidemiological data on genotype 6 in Thailand, its
increasing emergence needs a more thorough assessment of
its regional distribution, which might help in limiting its
spread and treatment. Therefore, we sought to apply
sequence analysis of the core region to understand the
molecular epidemiology and genetic diversification of the
HCV in order to study the main genotype 6 and also its
subtypes among blood donors from Thailand.
Materials and methods
Sample collection
Two hundred and forty serum samples, which were anti-
HCV antibody positive, were obtained from blood donors at
Phitsanulok Regional Blood Center, Phitsanulok province,
Thailand. The blood donors were from Phitsanulok,
Phetchabun, Kamphaengphet, Sukhothai, Tak, andPlease cite this article in press as: Sistayanarain A, Chaiwong S, Molecul
blood donors, Journal of Microbiology, Immunology and Infection (201Uttaradit provinces in Thailand. Serum samples used in this
study were obtained during the years 2006e2007. The study
was approved by the Human Ethics Committee of Naresuan
University, Phitsanulok, Thailand.
RNA extraction and reverse transcription
RNA was extracted from serum using PureLink Viral RNA/
DNA Kits (Invitrogen, USA) according to the manufacturer’s
instructions. RNA was reverse transcribed into comple-
mentary DNA by random primer.
Nested PCR for core gene
The partial core region of HCV was amplified by nested PCR
with two sets of oligonucleotide primers using the same opti-
mized condition as described previously.7 The first-round
amplification was carried out with outer sense (Sc2) 50-
GGGAGGTCTCGTAGACCGTGCACCATG-30 and outer antisense
primers (Ac2) 50-GAGMGGKATRTACCCCATGAGRTCGGC-30. The
second-round PCR was amplified with inner sense (Q2)
50AGGTCTCGTAGACCGTGCATCATG-30 and inner antisense
primers (AQ2) 50-CAYGTRAGGGTATCGATGAC-30. The first-
round PCR was conducted for 40 cycles according to the
following cycling parameters: preliminary 20 cycles at 94C for
1minute, 45C for 1minute, and72C for 1minute, followedby
20 cycles at 94C for 1 minute, 55C for 1 minute, and 72C for
1 minute. The-second-round PCR was conducted for 35 cycles
according to the following cycling parameters: 94C for 1 min-
ute, 55C for 1 minute, and 72C for 1 minute. The final
extension step was carried out at 72C for 7 minutes.
Direct nucleotide sequencing and phylogenetic
analysis by amino acid sequence
HCV genotyping was performed by direct nucleotide
sequencing and determined by Basic Local Alignment
Search Tool analysis [National Center for Biotechnology
Information site (NCBI)] and phylogenetic tree analysis.
Phylogenetic tree of the core amino acid sequences was
constructed using the neighbor-joining method by bootstrap
analysis with 1000 replicates in MEGA software (version
6.06) (www.megasoftware.net). External reference se-
quences for the phylogenetic construction were retrieved
from the Los Alamos HCV database (http://hcv.lanl.gov/
content/sequence/HCV/ToolsOutline.html) and NCBI.
All sequences obtained from the core region were submit-
ted to GenBank (accession numbers KF577403eKF577411,
KF577413eKF577415, KF577417eKF577433, KF577435e
KF577475, KF577477eKF577478, and KF577480eKF577493).
Amino acid sequence comparison of genotype 6
To determine the difference of amino acid residues among
various HCV-6 subtypes, amino acid sequences of HCV iso-
lates were aligned based on core region with ClustalW2 and
BioEdit software. The prototype sequences of HCV geno-
type 6 subtypes 6f, 6n, 6c, and 6i used for comparison were
as follows: D38078 (6f), DQ278894 (6n), D37843 (6c), and
D37850 (6i).ar characterization of hepatitis C virus genotype 6 subtypes in Thai
5), http://dx.doi.org/10.1016/j.jmii.2015.01.006
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Of the 240 anti-HCV antibody-reactive serum samples, 192
were successfully sequenced for the core region. HCV ge-
notypes were determined and phylogenetic analysis wasFigure 1. Phylogenetic tree of the partial core amino acid sequ
sequences are represented in accession numbers, genotype or subty
tree. The reference sequences are as follows: D38078, DQ278894,
strain for other strains with the same amino acid sequences of HC
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samples.
HCV-6 isolates were identified as having sequences
belonging to either subtype 6f (71, 84.5%), 6n (7, 8.3%), 6c
(4, 4.8%), or 6i (2, 2.4%). In this study, 6f was the majorences of HCV-6 subtypes isolated in this study. The reference
pe, and country of origin. Bootstrap values are indicated in the
D37843, and D37850. KF577491 is shown as the representative
V subtype 6f-2. HCV Z hepatitis C virus.
ar characterization of hepatitis C virus genotype 6 subtypes in Thai
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Table 1 HCV-6 subtypes distributed in five provinces of Thailand.
Province HCV-6 subtype Total
6f 6n 6c 6i
6f-1 6f-2
Phitsanulok 2 9 1 0 0 12
Phetchabun 9 27 4 0 2 42
Kamphaengphet 0 8 1 0 0 9
Sukhothai 0 1 0 0 0 1
Uttaradit 1 14 1 4 0 20
Total, n (%) 12 (14.3) 59 (70.2) 7 (8.3) 4 (4.8) 2 (2.40) 84 (100)
HCV Z hepatitis C virus.
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+ MODELsubtype of HCV genotype 6 (Fig. 1). Frequency distributions
of HCV-6 subtype in the different regions were investi-
gated. Subtypes 6f and 6n were most predominant in
Phetchabun province, whereas genotype 6c was found only
in Uttaradit province. All HCV subtype 6i samples were also
found in Phetchabun province (Table 1). Sequence varia-
tions among HCV-6 subtypes were aligned to compare
amino acid sequences in the core region (amino acid posi-
tions 33e115). All the determined HCV-6 subtypes showed
at least one amino acid difference and some showed as
many as seven residue differences (Fig. 2). In this study, the
comparison of amino acid sequences indicated that posi-
tions 70, 71, 75, 77, and 106 were different among the four
HCV subtypes (Fig. 2). The residue at position 70 ofFigure 2. Comparison of amino acid sequences alignment of HC
shown. The shaded columns and stars show significant changes in a
KF577490, and KF577414 are shown as representative strains for o
numbers 1e4 indicate HCV strains having the same amino acid
KF577441, KF577444, KF577448, KF577462, KF577467; (2) Z KF
KF577419eKF577420, KF577423eKF577424, KF577427eKF577429, K
KF577443, KF577445eKF577447, KF577450eKF577453, KF577455eK
KF577472eKF577473, KF577475. KF577477eKF577478, KF5774
(3) Z KF577490, KF577474, KF577460, KF577449, KF577442, K
HCV Z hepatitis C virus.
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blood donors, Journal of Microbiology, Immunology and Infection (201subtypes 6n and 6i was Q and P, whereas for subtypes 6f and
6c it was H. Amino acid P at position 71 was found in the
subtypes 6n and 6i but Q was found in the subtypes 6f and
6c. The HCV subtypes 6f and 6i showed amino acid S at
position 75, whereas subtypes 6n and 6c showed amino
acids H and T, respectively. Amino acid A at position 77 was
shown in the subtypes 6n, 6f, and most strains of subtype
6c, whereas G was detected in subtype 6i and one stain of
subtype 6c. The amino acid at position 106 of most subtypes
(6n, 6c, and 6i) was N, but for subtype 6f it was amino acid
H. Many substitutions in HCV subtype 6f were detected
(V34E/L, R43Q, E54K, R59K, V68A, H70R, Q71R, S75T, P82A,
P100L, P109S, R114L, and R115K), whereas three sub-
stitutions in subtype 6c were detected (A75T, A77G, andV genotype 6 subtypes. Amino acids consensus sequences are
mino acid position among HCV subtypes. KF577487, KF577491,
ther strains with same amino acid sequences. The superscript
sequences. (1) Z KF577487, KF577404, KF577406, KF577425,
577491, KF577405, KF577408eKF577411, KF57713, KF577417,
F577431, KF577433, KF577435eKF577437, KF577439eKF577440,
F577458, KF577461, KF577463eKF577465, KF577468, KF577470,
80, KF577482eKF577483, KF577485eKF577486, KF577489.
F577426, KF577418. (4) Z KF577414, KF577415, KF577471.
ar characterization of hepatitis C virus genotype 6 subtypes in Thai
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position 115 (R115K) was identified. Based on a comparison
of amino acid V or A at position 68, the HCV subtype 6f was
classified as 6f-1 and 6f-2 (Figs. 1 and 2).Discussion
HCV genotype 6 is known to circulate in Southeast Asian
countries, especially Thailand, Myanmar, Vietnam, and
Laos.6,7,10,11 Studies of HCV genotype have identified ge-
notype 6 in Southern China, Hong Kong, Taiwan, Macau, and
Korea.12e15 Southeast Asian immigrants living in Canada
also carry HCV genotype 6 infections.16 Of all HCV in-
fections, HCV-6 is the most prevalent in Myanmar (49%),
Vietnam (47.1%), Hong Kong (27.1%), and Thailand
(18e31%). HCV genotype 6 has the highest genetic diversity,
forming at least 22 subtypes worldwide (6ae6v).17 We
recently reported that genotype 6 has become more prev-
alent than genotype 1.7 There have been several studies on
genotype 6 subtypes between 1994 and 2014 from all re-
gions of Thailand.8,9,18e21 Although subtypes 6a, 6b, 6c, 6e,
6f, 6i, 6j, 6m, and 6n have been identified, the data are
insufficiently detailed to detect any time-dependent drift
in subtype drift as a whole or by region. The only clear
change has been the emergence of type 6v, which is com-
mon in northern Thailand.22 The results of this study show
that only four subtypes of HCV-6 (i.e., 6f, 6n, 6c, and 6i) are
present in Thailand. In particular, the HCV-6 subtype 6f
appears to be exclusive to Thailand.8 A variant of HCV-6 has
also been detected among workers from Cambodia and
Myanmar immigrating to Thailand.23 A new HCV-6 subtype
6n was found in Myanmar mainly within the northern cities
bordering China and India.10,24 Subtype 6n has also been
detected in Laos and was found in our samples (8.3%). Very
recently, a small number of subtype 6c has been obtained
from infected Korean patients by Seong et al15; however, in
this study, all of the subtype 6c sequences isolated from
blood donors were from Uttaradit province, Thailand. Our
study also indicated that HCV subtype 6i is rarely found in
Thailand. In addition, we found that HCV subtypes 6c and 6i
were restricted to areas of Uttaradit and Phetchabun
provinces close to Laos where these subtypes are found.
Nevertheless, subtype 6f was the most common subtype in
our samples, which reaffirms its high frequency in Thailand.
The nucleotide sequence of HCV genotype 6 subtypes
differed by 21e29%.25 We showed 1e8% variations (1e7
amino acid residues). It has been recommended that the
entire sequences should be identified for additional infor-
mation. The HCV core protein, composed of 191 amino acid
residues, consists of three domains, namely, an N-terminal
hydrophilic domain (positions 1e117), a C-terminal hydro-
phobic domain (positions 118e170), and the hydrophobic
signal sequence.26,27 A total of 83 amino acid residues of
Thai HCV subtype 6f were compared with HCV reference
strain (D38078). In this study, we found 13 amino acid
substitutions in the HCV subtype 6f, whereas there were
three substitutions in subtype 6c. Interestingly, the amino
acid at position 68 of HCV subtype 6f showed substitution of
V for A in 83% (59/71) of samples. Amino acid V or A at
position 68 allowed for further classification of subtype into
6f-1 and 6f-2, respectively (Fig. 2), but there was noPlease cite this article in press as: Sistayanarain A, Chaiwong S, Molecul
blood donors, Journal of Microbiology, Immunology and Infection (201geographic association in this regard. In this study, amino
acid sequences of HCV subtype 6n were conserved
compared with the corresponding reference strain, which is
in accordance with a previous study (amino acid positions
33e115) on individuals in Thailand with subtype 6n.8 HCV
subtype 6n showed no difference in amino acid sequences,
suggesting same historic transmission routes. However,
historic information about blood donors was unavailable.
For subtype 6i, only one amino acid substitution at position
115 (R115K) was identified. The core protein is involved in
the association of various pathways that are important to
the HCV life cycle.28 Polymorphisms of amino acid in the
core region influences antiviral therapy and the severity of
liver disease.29,30 Mutation of core protein at position 70
(R70Q, R70H) and/or 91 (L70M) of genotypes 1b and 4d is
associated with poor interferon treatment outcomes.29,31
Likewise, HCV-6 subtype 6f is more resistant to combined
pegylated interferon and ribavirin treatment than geno-
types 1 and 3.21 However, there are no data relating to drug
treatment and residue changes in the core region for ge-
notype 6.
In conclusion, of the four HCV-6 subtypes in this study
(i.e., 6f, 6n, 6c, and 6i), the HCV-6 subtype 6f appears to be
exclusive to Thailand. There were modest variations in the
core region of these four HCV-6 subtypes. However,
because the samples were from healthy donors, there was
no information to correlate the data, which might predict
treatment outcomes. Thus, further study on the epidemi-
ology of the HCV genotype 6 in the whole region of Thailand
is important.
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